Suppr超能文献

非编码RNA在神经性疼痛方面的研究进展

Advances With Non-coding RNAs in Neuropathic Pain.

作者信息

Hu Cheng, He Menglin, Xu Qian, Tian Weiqian

机构信息

Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.

出版信息

Front Neurosci. 2021 Dec 23;15:760936. doi: 10.3389/fnins.2021.760936. eCollection 2021.

Abstract

Neuropathic pain (NP) is one of the most common types of clinical pain. The common causes of this syndrome include injury to the central or peripheral nervous systems and pathological changes. NP is characterized by spontaneous pain, hyperalgesia, abnormal pain, and paresthesia. Because of its diverse etiology, the pathogenesis of NP has not been fully elucidated and has become one of the most challenging problems in clinical medicine. This kind of pain is extremely resistant to conventional treatment and is accompanied by serious complications. Non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), contribute to diverse biological processes by regulating the expression of various mRNAs involved in pain-related pathways, at the posttranscriptional level. Abnormal regulation of ncRNAs is closely related to the occurrence and development of NP. In this review, we summarize the current state of understanding of the roles of different ncRNAs in the development of NP. Understanding these mechanisms can help develop novel therapeutic strategies to prevent or treat chronic pain.

摘要

神经病理性疼痛(NP)是临床疼痛中最常见的类型之一。该综合征的常见病因包括中枢或外周神经系统损伤以及病理变化。NP的特征是自发性疼痛、痛觉过敏、异常疼痛和感觉异常。由于其病因多样,NP的发病机制尚未完全阐明,已成为临床医学中最具挑战性的问题之一。这种疼痛对传统治疗极具抗性,并伴有严重并发症。非编码RNA(ncRNAs),如微小RNA(miRNAs)、长链非编码RNA(lncRNAs)和环状RNA(circRNAs),通过在转录后水平调节参与疼痛相关途径的各种mRNA的表达,参与多种生物学过程。ncRNAs的异常调节与NP的发生和发展密切相关。在本综述中,我们总结了目前对不同ncRNAs在NP发生发展中作用的理解现状。了解这些机制有助于开发预防或治疗慢性疼痛的新治疗策略。

相似文献

1
Advances With Non-coding RNAs in Neuropathic Pain.
Front Neurosci. 2021 Dec 23;15:760936. doi: 10.3389/fnins.2021.760936. eCollection 2021.
3
The role of non-coding RNAs in neuropathic pain.
Pflugers Arch. 2024 Nov;476(11):1625-1643. doi: 10.1007/s00424-024-02989-y. Epub 2024 Jul 17.
4
The emerging power and promise of non-coding RNAs in chronic pain.
Front Mol Neurosci. 2022 Nov 3;15:1037929. doi: 10.3389/fnmol.2022.1037929. eCollection 2022.
6
A transcriptomic profile of topping responsive non-coding RNAs in tobacco roots (Nicotiana tabacum).
BMC Genomics. 2019 Nov 14;20(1):856. doi: 10.1186/s12864-019-6236-6.
7
Interactions Among Non-Coding RNAs and mRNAs in the Trigeminal Ganglion Associated with Neuropathic Pain.
J Pain Res. 2022 Sep 22;15:2967-2988. doi: 10.2147/JPR.S382692. eCollection 2022.
8
The role of circular RNAs in neuropathic pain.
Neurosci Biobehav Rev. 2022 Jan;132:968-975. doi: 10.1016/j.neubiorev.2021.10.048. Epub 2021 Nov 2.
9
Long Non-coding RNAs and Circular RNAs: Insights Into Microglia and Astrocyte Mediated Neurological Diseases.
Front Mol Neurosci. 2021 Oct 5;14:745066. doi: 10.3389/fnmol.2021.745066. eCollection 2021.
10
Functional roles of lncRNAs and its potential mechanisms in neuropathic pain.
Clin Epigenetics. 2019 May 15;11(1):78. doi: 10.1186/s13148-019-0671-8.

引用本文的文献

1
The involvement of spinal lncRNA RT1-CE10 in chronic functional visceral pain.
Mol Pain. 2025 Jan-Dec;21:17448069251358692. doi: 10.1177/17448069251358692. Epub 2025 Jul 3.
4
RNA Interference Unleashed: Current Perspective of Small Interfering RNA (siRNA) Therapeutics in the Treatment of Neuropathic Pain.
ACS Pharmacol Transl Sci. 2024 Sep 23;7(10):2951-2970. doi: 10.1021/acsptsci.4c00329. eCollection 2024 Oct 11.
6
Communicating pain: emerging axonal signaling in peripheral neuropathic pain.
Front Neuroanat. 2024 Jul 9;18:1398400. doi: 10.3389/fnana.2024.1398400. eCollection 2024.
7
Pharmacogenetic landscape of pain management variants among Mediterranean populations.
Front Pharmacol. 2024 May 15;15:1380613. doi: 10.3389/fphar.2024.1380613. eCollection 2024.
10
Global research trends on epigenetics and neuropathic pain: A bibliometric analysis.
Front Mol Neurosci. 2023 Apr 19;16:1145393. doi: 10.3389/fnmol.2023.1145393. eCollection 2023.

本文引用的文献

1
miR-223 Inhibits the Polarization and Recruitment of Macrophages via NLRP3/IL-1 Pathway to Meliorate Neuropathic Pain.
Pain Res Manag. 2021 Aug 6;2021:6674028. doi: 10.1155/2021/6674028. eCollection 2021.
2
Overexpression of miR-378 Alleviates Chronic Sciatic Nerve Injury by Targeting EZH2.
Neurochem Res. 2021 Dec;46(12):3213-3221. doi: 10.1007/s11064-021-03424-9. Epub 2021 Aug 18.
5
Downregulating lncRNA PVT1 Relieves Astrocyte Overactivation Induced Neuropathic Pain Through Targeting miR-186-5p/CXCL13/CXCR5 Axis.
Neurochem Res. 2021 Jun;46(6):1457-1469. doi: 10.1007/s11064-021-03287-0. Epub 2021 Mar 19.
6
MiR-122-5p suppresses neuropathic pain development by targeting PDK4.
Neurochem Res. 2021 Apr;46(4):957-963. doi: 10.1007/s11064-020-03213-w. Epub 2021 Feb 10.
8
LncRNA NEAT1/miR-128-3p/AQP4 axis regulating spinal cord injury-induced neuropathic pain progression.
J Neuroimmunol. 2021 Feb 15;351:577457. doi: 10.1016/j.jneuroim.2020.577457. Epub 2020 Dec 9.
9
Knockdown of miR-130a-3p alleviates spinal cord injury induced neuropathic pain by activating IGF-1/IGF-1R pathway.
J Neuroimmunol. 2021 Feb 15;351:577458. doi: 10.1016/j.jneuroim.2020.577458. Epub 2020 Dec 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验